Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why such a big difference between bid and ask?
NAKAYAMA. I probably missed it but I don't recall hearing of Nakayama and amorphous alloy before. How does their work relate to our patents? This seems like a possible infringement, but I don't think Apple would allow that unless Apple is also working with them. Anyone? Is Nakayama a direct competitor?
Someone should ask Materion, "What progress is being made with your expectatios for LiquidMetal?"
I know that its on their website, but when was it added.? Is it new or something tthat they added right after the agreement?., I don't mean to be difficult, but it does matter when Materion posted that because I suspect Materion has now lost all faith in LM.
I would love to know the date of that publication. Anyone?
Thanks for the answer. Do you know if the people doing themselves are doing it subcutaneously?
We are the only subcutaneous methodrexate, aren't we?
Turnkey manufacturing? Can this be done without Visser's consent?
When did you speak to Tony Chung? Where did you reach him? What else did he say?
I'm in awe of you.
tappy, your comment on post 2401, please.
Just the facts. I see you're not a regular poster on the ATRS board but rather post on the ANIP board. Please take a look at post 2401 on ATRS and tell me your take on it.
re: Libigel. I don't know if this is new to anyone but I just found it and I read it as a right reserved to ATRS to cancel ANIP/BPAX's rights to Libigel upon failure to pursue FDA's approval. This is taken from a BPAX filing with the SEC.
Re: BioSante Pharmaceuticals, Inc.
Form 10-K for the fiscal year ended December 31, 2011
Filed March 13, 2012
File No. 001-31812
"The term of our license agreement with Antares will expire on a country-by-country and product-by-product basis when the royalties expire (at patent expiration), at which time we will have a fully paid-up exclusive license regarding the applicable product in such country. We and Antares may terminate the license agreement upon the occurrence of certain events, including a material breach of the agreement by the other party or if the other party goes into liquidation or bankruptcy or makes an assignment for the benefit of creditors or a receiver is appointed. Antares may terminate the agreement with respect to certain products or territories if we do not continue development, seeking regulatory approval or marketing of such products in the covered territories. We may terminate the agreement with respect to certain products or territories if, for technical, scientific or regulatory reasons, it is not likely that the product will gain required regulatory approvals in a territory, if regulatory approvals in a territory are not obtained or if we determine that it is not economically viable to continue development or marketing of a product in a territory.”
Thank you ever so much. I've spent considerable time trying to find something as to the future of Libigel.
Notwithstanding the unanticipated placebo effect, I have remained a firm believer in a future of Libigel.
I believe the test protocols were at fault for the high placebo outcome. I am now an avid believer in ATRS, but I think Libigel will ultimately prove to be its most valuable asset. What I don't know, and perhaps you can help, what was the nature of the agreement between Antares and Biosante? I would imagine that if Anip conveys it's interest in the drug, Antares will remain a beneficiary to the same extent. If some third-party pursues the patents you spoke of, do you know how Antares will stand. I'm a newcomer to ATRS but I believe Libigel will be a big part of it's future.
It was a pleasure reading your post. It appears that you share some of my sentiments about Libigel.
I was hoping it was the "undisclosed" product in the pipeline, but I just noticed that that product is "otc".
It would have been nice. Libigel is he reason I bought into ATRS. I still haven't given up on it and for awhile it looked as if BPAX was going to continue with it. All the safety test results should be worth something to someone.
ANIP owns no more than BPAX and that was only the north american rights. Plus, ANIP has gone on record stating they have no interest in pursuing Libigel. I'm sure Pfyser could easily buy back ANIP's rights. I'm not trying to be contrary but both Pfyser and Antares have mor to gain from a Libigel offshoot than from any other drug.
LIBIGEL Does anyone else think Pfizer might want what's left of Libigel and some form of that may be the secret product they are working on together? Pfizer would just love to have a female Viagra.
Liquidmetal for eyeglass frames?
I'd like it confirmed that it was a phony interview. I think watts on the Materion board believes it was a real interview.
if funkjt made up that post about meetingt with Rasmussin he should be permanently banned from this board and from iHub. I believe the post has now been deleted.
Hey funkjt there seems to be some question on this board as to your veracity. I think you owe it to us to explain
when and under what circumstances you met with Rasmussen. Why would he reveal all of this information to you?
The presentations at the Aegis conferences must have been predictably underwhelming. Did anyone hear anything?
If the ingots were for consumer electronics only, I don't see where Crucble would be invoved . There is still the question of whether Materion would have to pay Lqmt anything for ingots used for Apple. I think not.
Apple doesn't have to buy its ingots from Materion if they can come up with another source, and maybe Apple can license Materion to make ingots for consumer electronics. Just a thought, but your question is a good one.
I'm not a pumper, and i don't know if this is allowed on this board, but 2 other stocks that I own , and like Sglb have great technology and enormous long-term potential are Lqmt and Actc. You might want to take a look, at least as to their unique technology. This does sound like it doesn't belong on this board but both are similar in many ways to Sglb. Sorry if I shouldn't have.
I'm still not too confident out charts. I know that if SGLB has signifiant news, especially as it might effect earnings, pps is going up no matter what the charts say. I rely first on real news, second, my own dd as to the soundness and marketability of what they're selling and then what I can garner from charts from those who appear to know what they're talking about. And, I know enough to recognize someone who doesn,t know what he's talking about. And, empty pumping is worse than useless. Thanks again for your contribution to this board.
ddm, I know nothing about the technicals but i appreciate your posts. It seems like you really know what your talking about and without news what else is there?. I go by the technology and SGLB is in the right place at the right time. Please keep your posts coming.
How long do shorts have to cover?
OMG! Gary is going to be in Las Vegas.
I believe it was previously posted on this board that Visser personally and with the various entities that he owns had a controlling vote. i know it was the subject of debate here.
Visser vote. Since Visser apparently has enough votes to control an election, at this stage can he substitute his nominees for election to the BOD?
And make a deal with Visser? What do you think is Visser's plan?
watts, I also am glad i found you. I enjoyed and learned quite a bit at the lqmt board.
For what it's worth, i also believe that Materion will/should acquire lqmt. But it seems that as part of their move they should some how buyout Visser. As a successor to lqmt's rights do you think they could manufacture without violating Visser's rights? It might depend on wether Lqmt reserved the right to manufacture in competition with Visser. 'nother question, might Lqmt merge with Materion in some kind of a stock swap?
My point is, if you're going to post something like that give a date or a link. Otherwise it does sound like something "new"
That's from a July 12 article in VisionAware. Hardly anything new.
I'm sorry, I thought they were liquidmetal as they originally claimed and and that they are being made under a 10 year non-exclusive license to Chang. If you have better information, please share it with us.
Vmatter comparison with damascus steel
https://www.vmatter.com/our-technology/vmatter-technology/
Hey, they could sell knives. JMatter points out on its website that some damascus steel knives sell for over $1000.
Article/interview with Jason Kolbert on Stem Cell companies, but before Maxim covered ACTC.
Sorry if it was previously posted and its a little dated.
http://www.thelifesciencesreport.com/pub/na/position-yourself-for-big-returns-in-the-stem-cell-space-jason-kolbert